Ta-Sen Yeh Selected Research

Cholecystostomy

9/2021	The optimal timing of interval laparoscopic cholecystectomy following percutaneous cholecystostomy based on pathological findings and the incidence of biliary events.
1/2021	Alternative application of percutaneous cholecystostomy in patients with biliary obstruction.
1/2021	Management of Patients With Acute Cholecystitis After Percutaneous Cholecystostomy: From the Acute Stage to Definitive Surgical Treatment.
8/2020	Surgical outcomes of patients with maintained or removed percutaneous cholecystostomy before intended laparoscopic cholecystectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ta-Sen Yeh Research Topics

Disease

68	Neoplasms (Cancer) 06/2022 - 05/2002
28	Stomach Neoplasms (Stomach Cancer) 04/2022 - 01/2011
23	Cholangiocarcinoma 03/2022 - 05/2004
13	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2010
13	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 04/2003
12	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 06/2014
8	Adenocarcinoma 01/2019 - 04/2005
7	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
6	Body Weight (Weight, Body) 05/2020 - 07/2011
5	Hemorrhage 02/2022 - 11/2012
5	Weight Loss (Weight Reduction) 01/2022 - 03/2018
5	Acute Cholecystitis 09/2021 - 01/2020
5	Pancreatic Neoplasms (Pancreatic Cancer) 06/2021 - 04/2007
5	Wounds and Injuries (Trauma) 05/2017 - 11/2012
5	Carcinogenesis 01/2017 - 02/2006
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 07/2016
4	Margins of Excision 11/2018 - 01/2014
4	Hemorrhagic Shock 05/2017 - 11/2012
4	Carcinoma (Carcinomatosis) 01/2017 - 01/2005
4	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 01/2012
3	Inflammation (Inflammations) 03/2022 - 05/2011
3	Obesity 01/2022 - 11/2018
3	Metaplasia 01/2018 - 05/2002
3	Fibrosis (Cirrhosis) 01/2018 - 10/2004
3	Shock 01/2015 - 11/2012
2	Pain (Aches) 01/2022 - 05/2009
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2016
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 01/2013
2	Microsatellite Instability 01/2020 - 12/2019
2	Body Weight Changes 01/2019 - 11/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 10/2004

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2003
10	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 06/2014
10	hydroxide ionIBA 07/2018 - 01/2012
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
8	19- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3IBA 07/2018 - 01/2012
7	Caspase 3 (Caspase-3)IBA 01/2018 - 03/2008
7	MucinsIBA 01/2018 - 05/2002
7	Vitamin D FDA LinkGeneric 01/2017 - 01/2012
6	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2012
6	Sunitinib (Sutent)FDA Link 01/2021 - 09/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2008
4	salicylhydroxamic acid (SHAM)IBA 05/2017 - 11/2012
4	Protein Isoforms (Isoforms)IBA 08/2016 - 09/2006
3	Biological ProductsIBA 01/2022 - 04/2003
3	Hormones (Hormone)IBA 01/2021 - 01/2012
3	regorafenibIBA 01/2021 - 12/2017
3	RNA (Ribonucleic Acid)IBA 12/2019 - 09/2006
3	CarbohydratesIBA 11/2018 - 05/2012
3	AntigensIBA 11/2018 - 05/2012
3	Estrogen ReceptorsIBA 07/2018 - 01/2012
3	Pharmaceutical PreparationsIBA 07/2018 - 06/2014
3	Gemcitabine FDA Link 01/2018 - 01/2016
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 01/2012
3	Adenosine Triphosphate (ATP)IBA 05/2017 - 11/2012
3	Peroxidase (Myeloperoxidase)IBA 05/2017 - 11/2012
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017 - 06/2014
3	EnzymesIBA 08/2016 - 09/2005
3	ErbB Receptors (EGF Receptor)IBA 09/2015 - 07/2004
3	Messenger RNA (mRNA)IBA 03/2015 - 03/2008
3	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2015 - 11/2012
3	AlbuminsIBA 05/2013 - 05/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 10/2004
3	Thioacetamide (Thioacetamid)IBA 03/2008 - 07/2004
2	Matrix Metalloproteinases (MMPs)IBA 03/2022 - 07/2004
2	Hemoglobins (Hemoglobin)IBA 02/2022 - 04/2015
2	Everolimus FDA Link 01/2021 - 01/2018
2	Histone DemethylasesIBA 10/2020 - 01/2019
2	Inosine Triphosphate (ITP)IBA 01/2020 - 01/2013
2	CholesterolIBA 01/2019 - 07/2003
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 12/2015
2	Aurora Kinase AIBA 09/2018 - 06/2014
2	Eukaryotic Initiation Factor-4EIBA 01/2018 - 03/2008
2	Carcinoembryonic AntigenIBA 01/2018 - 09/2005
2	Cetuximab (Erbitux)FDA Link 01/2018 - 01/2016
2	Alanine Transaminase (SGPT)IBA 05/2017 - 11/2012
2	Malondialdehyde (Propanedial)IBA 05/2017 - 11/2012
2	MelatoninIBA 05/2017 - 11/2012
2	SB 203580IBA 05/2017 - 01/2015
2	p38 Mitogen-Activated Protein KinasesIBA 05/2017 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 01/2016
2	MineralsIBA 01/2017 - 01/2016

Therapy/Procedure

23	Gastrectomy 06/2022 - 04/2003
13	Hepatectomy 03/2022 - 01/2005
13	Therapeutics 01/2022 - 05/2010
11	Drug Therapy (Chemotherapy) 04/2022 - 06/2004
8	Laparotomy 08/2020 - 04/2003
5	Bariatric Surgery 01/2022 - 01/2018
5	Cholecystectomy 08/2020 - 01/2005
5	Splenectomy 01/2020 - 04/2010
5	Adjuvant Chemotherapy 01/2020 - 02/2010
5	Lymph Node Excision (Lymph Node Dissection) 12/2019 - 08/2014
4	Radiotherapy 01/2022 - 03/2005
4	Cholecystostomy 09/2021 - 08/2020
4	Resuscitation 05/2017 - 11/2012
3	Pancreaticoduodenectomy 01/2022 - 02/2010
3	Operative Time 03/2018 - 01/2014
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2018 - 01/2015
2	Decompression 01/2022 - 12/2012
2	Cytoreduction Surgical Procedures 01/2021 - 03/2017